Synergism and rules from combination of Baicalin, Jasminoidin and Desoxycholic acid in refined Qing Kai Ling for treat ischemic stroke mice model. by Li, J et al.
Synergism and Rules from Combination of Baicalin,
Jasminoidin and Desoxycholic acid in Refined Qing Kai
Ling for Treat Ischemic Stroke Mice Model
Jian Li1., Run-guo Wu2., Fan-yun Meng3., Zhong Wang4, Chang-ming Wang2, Yong-yan Wang4, Zhan-
jun Zhang2*
1 School of Basic Medical Science, Beijing University of Chinese Medicine, Beijing, People’s Republic of China, 2 State Key Laboratory of Cognitive Neuroscience and
Learning, Beijing Normal University, Beijing, China, 3 School of Resources Science & Technology, Beijing Normal University, Beijing, China, 4 Institute of Basic Research in
Clinical Medicine, China Academy of Traditional Chinese Medicine, Beijing, China
Abstract
Refined Qing-Kai-Ling (QKL), a modified Chinese medicine, consists of three main ingredients (Baicalin, Jasminoidin and
Desoxycholic acid), plays a synergistic effect on the treatment of the acute stage of ischemic stroke. However, the rules of
the combination and synergism are still unknown. Based on the ischemic stroke mice model, all different kinds of
combination of Baicalin, Jasminoidin, and Desoxycholic acid were investigated by the methods of neurological examination,
microarray, and genomics analysis. As a result, it confirmed that the combination of three drugs offered a better
therapeutical effect on ischemic stroke than monotherapy of each drug. Additionally, we used Ingenuity pathway Analysis
(IPA) and principal component analysis (PCA) to extract the dominant information of expression changes in 373 ischemia-
related genes. The results suggested that 5 principal components (PC1-5) could account for more than 95% energy in the
gene data. Moreover, 3 clusters (PC1, PC2+PC5, and PC3+PC4) were addressed with cluster analysis. Furthermore, we
matched PCs on the drug-target networks, the findings demonstrated that Baicalin related with PC1 that played the leading
role in the combination; Jasminoidin related with PC2+PC5 that played a compensatory role; while Desoxycholic acid had
the least performance alone which could relate with PC3+PC4 that played a compatible role. These manifestations were
accorded with the principle of herbal formulae of Traditional Chinese Medicine (TCM), emperor-minister-adjuvant-courier. In
conclusion, we firstly provided scientific evidence to the classic theory of TCM formulae, an initiating holistic viewpoint of
combination therapy of TCM. This study also illustrated that PCA might be an applicable method to analyze the complicated
data of drug combination.
Citation: Li J, Wu R-g, Meng F-y, Wang Z, Wang C-m, et al. (2012) Synergism and Rules from Combination of Baicalin, Jasminoidin and Desoxycholic acid in Refined
Qing Kai Ling for Treat Ischemic Stroke Mice Model. PLoS ONE 7(9): e45811. doi:10.1371/journal.pone.0045811
Editor: Ken Arai, Massachusetts General Hospital/Harvard Medical School, United States of America
Received March 5, 2012; Accepted August 22, 2012; Published September 26, 2012
Copyright:  2012 Li et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the program for new century excellent talents in University (No. NCET-10-0249), the Program for excellent doctoral
dissertation foundation (No. 2007B7) and by the project of institute of basic research in clinical medicine (No. Z0175). The funders had no role in study design,
data collection and analysis, decision to publish, or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: zhang_rzs@bnu.edu.cn
. These authors contributed equally to this work.
Introduction
Stroke, one of the most common neurological disorders and the
third leading cause of death in the worldwide (ranking behind
heart disease and all forms of cancer), can be classified into two
major categories: ischemic and hemorrhagic [1]. Due to 87% of
strokes are caused by ischemia, it has become the focus of many
researchers. However, there is no routine effective, generally
accepted and specific treatment for ischemic stroke yet, except for
aspirin and thrombolytic treatment with recombinant tissue
plasminogen activator for highly selected patients [2,3].
Nevertheless, stroke is much more complex than initially
anticipated because it is often caused by multiple molecular
abnormalities, rather than being the result of a single effect. For
this reason, it is huge challenge for specific-target drug or mono-
therapy to impact on many aspects of clinical trials. In this regard,
the application of combinational drugs or polypill, in which two or
more drugs interact with multiple targets simultaneously, is
considered as a rational and efficient form of therapy designed
to control complex diseases such as stroke[4–6].
Interestingly, Traditional Chinese Medicine (TCM), from the
viewpoint of holism, always advocates drug-combined adminis-
trations. Over thousands of years, prescriptions of TCM called as
formulae are made by practitioners according to their experience
and heritage from ancestors [7]. We and other researchers
demonstrated that some TCM preparations (e.g. Qing-Kai-Ling,
Xue-Se-Tong, and Dan-Shen, etc.) showed effectiveness for the
treatment of stroke by anti-oxidation, anti-inflammation, protect-
ing against ischemic reperfusion injury, and enhancing the
tolerance of ischemic tissue to hypoxia [8–10]. Among them,
Qing-Kai-Ling (QKL) was from a modifying traditional Chinese
medicine, An-Gong-Niu-Huang Pill. It was widely used in clinical
to treat acute stages of cerebrovascular diseases [11–13],
inflammatory related diseases, and so on [14–16]. Considering
the complex components, quality stabilization, and clinical safety,
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the refined QKL injection was developed to aim at acute ischemic
stroke for 20 years [13,17]. Refined QKL injection consists of
Baicalin, Jasminoidin and Desoxycholic acid (Fig. 1), which proved
effective for the treatment of ischemic stroke through protecting
neurological impairment and secondary lesions [18]. However, the
studies of combinational rules and roles of each ingredient in QKL
have not been reported.
In present study, we used methods of neurological examination,
histochemistry and microarray to compare the efficacy of various
kinds of combined and single forms of 3 ingredients to treat
cerebral ischemia mouse model. Moreover, we attempted several
mathematics algorithms and systems biology analysis methods to
reveal the rules of combination of drugs.
Results
The effect of drug individual and combinations on
neurological deficit and ischemic infarct
We firstly investigated the behavior scores at 3 hrs and 24 hrs
after MCAO to evaluate the beneficial effects of the treatment
with the various combined drugs. The results showed the behavior
scores was not significant difference between each group at 3 hrs
after reperfusion (data not show), while at 24 hrs, the scores of
ABC and AB treatment group are significantly higher than model
group (M) (Fig. 2a). The cerebral infarct volumes were later on
measured by computer image analysis of TTC-stained 2 mm thick
brain sections. The results showed that in drug A, AB, AC, and
ABC treated mice, the percentage of infarct volume was
significantly reduced than that in model control mice (Fig. 2b).
Image analysis and statistical results showed that the drug treated
groups except C had significant lower infarct volumes than M and
ABC was lower than any other groups (Fig. 2c). Factorial analysis
demonstrated that the factor A was the primary contribution for
the efficacy of the drugs (Fig. 2d).
Drug individual and combinations match different bio-
network and biology functions
The present mRNA microarray had 373 ischemic stroke related
genes. Three mice of each group were sampled and each sampling
was repeated four times in the microarrays. Consequently, twelve
parallel outcomes of one gene in one group were observed and
means of all the parallel outcomes were used to describe the genes’
performances in different conditions. To validate the microarray
results, real-time polymerase chain reaction (qRT-PCR) was used
to confirm the expression of selected genes, including F5,
Sh2bpsm1, Il1a, Dusp4, Rgs6 and Gpx2. The outcome of qRT-
PCR indicated that broad, array-based gene expression measure-
ments were reliable for determining gene expression patterns in
the brain (figure S1).
Based on Ingenuity Pathways Knowledge base (IPA), 46
selected drug-target genes, fold = 21.5 to +1.5, were overlaid
onto a global molecular network developed from information
contained in the IPA base (table S1). Networks of these focus
molecules were then algorithmically generated based on their
connectivity. The results showed that about 32 bio-functions were
affected by various drug combinations, the top 10 is in turn: 1)
gene expression, 2) cellular growth and proliferation, 3) organismal
development, 4) cell death, 5) cellular development, 6) develop-
ment disorder, 7) organ development, 8) tissue development, 9) cell
cycle, and 10) nervous system development and function. The
functional analysis identified the probability (p-value), each
biological function assigned to various combined drugs demon-
strated that the AB, AC, and ABC combinations can addressed
higher p-value than BC combination, which suggested the
outcomes from gene expression profiles have correlations between
scores from neuro-pathological examination (Fig. 3).
Principal component analysis (PCA) to expose genes
profiles and combinative effects of drugs
To investigate the combinational effects of A, B and C, principal
component analysis (PCA) was used to analysis gene expression
profiles. Figure 4a showed that five components could account for
more than 95% energy in the gene data without losing useful
information. Every gene had a transformed score for a specified
experimental group in a principal component (PC). From the
distributions, 60.2 could be appointed a cutoff to select the genes
with the greatest contribution. Consequently, there were 50, 31,
24, 26 and 30 genes with a value above the threshold, respectively
from PC1 to PC5 (Figure 4b, table S2). In total, 72 genes and 79
cell processes in any PC above this threshold were selected as
targets. To analyze this result, we distinguished 52 (65.8%)
processes playing a role in ischemic pathology and recovery from
the total 79 processes, according to the known ischemic stroke
process [19–21] and previous reports in ISI Web of Knowledge. In
detail, PC1 accounted for most processes, a considerable part of
which were exclusive, PC2 + PC5 had many shared processes and
a few exclusive one, and PC3 + PC4 were evidently concentrated
in high commonness classes (Figure 4c). In order to further unveil
the relationship between each ingredient with PCs, we matched
each PC on drug-target networks. The results showed that the
drug A had the best performance in PC1 (Fig. 5a), drug B had
similar performances with A related with PC2+PC5 (Fig. 5b), drug
C evidently had the least performance alone, but it can be
matched with PC3+PC4 (Fig. 5c).
Figure 1. The structures of baicalin, jasminoidin and desoxycholic acid. (a) Baicalin. (b) Jasminoidin. (c) Desoxycholic acid.
doi:10.1371/journal.pone.0045811.g001
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Discussion
Multi-component therapeutics, in which two or more agents
interact with multiple targets simultaneously, is considered as a
rational and efficient form of therapy designed to control complex
diseases [4,22]. Researchers hypothesize that synergism from
combinations may be greater than the sum of the individual effects
[6,23]. Recently, some researchers have made good attempts in
this explanation using approaches of system biology and network
pharmacology to identify the combinational roles of multi-
component therapeutics from Chinese medicines [24]. However,
these researches still need to be verified through many exper-
iments. We and others have shown that refined QKL offered
protective effects on focal cerebral ischemia-reperfusion injury
[9,10,13,18,25–27]. To further understand the synergistic effect
and combinational rules, in present study, we designed seven
combinations from three drugs to treat cerebral ischemia on mice
MCAO models. From the TTC staining data and behavior scores,
we found the AB, AC, and ABC combinations remarkably
ameliorate brain damage. These initial results suggest the
combinational drugs do offer better therapeutic effect on cerebral
ischemia. In these experiments, Drug A, Baicalin, is a major
flavonoid derived from and regarded as the active ingredient of a
Chinese herbal, Scutellaria baicalensis Georgi. It proved to be effective
in inhibiting oxidative-stress-induced apoptosis, attenuating the
elevated levels of Glu and Asp induced by cerebral ischemia and
resisting lipopolysaccharide (LPS)-induced inflammation [10].
Drug B, Jasminoidin, derived from the dried fruit of Gardenia
Figure 2. The results of pharmacodynamic effect on MACO. (a) The neurological examination scores (behavior test). According to the
principle of the neurological examination, a lower score means a worse pathological condition. The score of each experimental group came from the
average of sixteen subjects’ behavioral performances. (b) The TTC staining results. A higher proportion of cerebral infarct means a worse ischemic
injury. The same sixteen subjects as those in neurological examination for each experimental group were used. (c) The image analysis results. A
higher proportion of cerebral infarct means more severe in ischemic injury, n = 16, mean 6SE. *p,0.05, **p,0.01 vs model control. (d) The results of
factorial analysis on drug A, B and C.
doi:10.1371/journal.pone.0045811.g002
Figure 3. The Top 10 bio-functions analyzed by ingenuity pathway analysis ingenuity system (IPA).
doi:10.1371/journal.pone.0045811.g003
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Jasminoides Ellis and is effective to attenuate the neuronal death in
the modeled ischemic environment [24]. Drug C, Desoxycholic
acid, widely used in TCM, is effective to improve digestive
function [28]. To illuminate the synergism and rules from
combination of Baicalin, Jasminoidin and Desoxycholic acid, we
employ mRNA microarray to observe the expression profiles after
different therapeutic administrations. Based on our present study,
we chose a custom mRNA microarray, on which 373 ischemia-
related genes were selected according to the previous studies or
related pathways. In this microarray, probe genes were mainly
involved in cell communication, developmental process, negative
regulation of biological process, cell death, wnt signaling pathway,
positive regulation of biological process, catalytic activity and
regulation of a molecular function. After ischemia-reperfusion,
most of them were down-regulated, which is coincident with the
previous studies [29–31]. All of our designed protocols made a
majority of genes up-regulated, compared to the model group and
their changing tendencies had high positive correlations with
sham/model. Based on IPA software, which drawn on published,
peer-reviewed literature, the bio-functions demonstrated that all
kinds of designed drug-administrations, especially ABC combina-
tions, had positive effects in regulating gene expressions after
Figure 4. Principal component analysis of the gene expression profiles. (a) The Principal component analysis (PCA) energy ranking, in which
the top five Principal components (PCs) account for .95% of total energy. (b) The distribution of the 373 genes in the five PCs, according to their
normalized PCA values. Most of genes in each PC are located between 60.2, while the minorities of genes outside this range are selected as
dominant genes of a PC. (c) The clustering of PCs. Distributions of dominant genes shows that PC 2 and PC 5, and PC 3 and PC 4 have the similar
mode, but PC 1 is unique.
doi:10.1371/journal.pone.0045811.g004
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ischemia-reperfusion. However, this analysis might not tell us the
essence of the molecular mechanisms of combinative effects,
considering that we could not find any relations in these quantities
and pharmacodynamic results. It was ambiguous to make clear the
quantitative correlation between genes performance and thera-
peutic effects.
As has been suggested in western medicine studies, different
composition materials may elicit different biochemical responses
and they are thus intentionally used to regulate the corresponding
physiological mechanisms. Consequently, the measured effects in
genes usually combine several independent unique drug effects.
Since the aim of this study is to investigate the combinational
effects of drugs, it is reasonable to decompose the representation
features of multiple genes into several functional groups that are
sensitive to different combination of drugs. In bioinformatics,
Principal component analysis (PCA) is an efficient and effective
feature selection method, which has been widely used in a variety
of scientific fields to extract the common patterns from multiple
observation samples. Hence, PCA is a perfect tool for our purpose,
whose power has been validated by previous genomic studies
[32,33]. In the present study, the top five principal components
(PCs) could explain more than 95% of variation of gene profiles in
different experimental groups and were selected to analyze.
In principal gene analysis of PCA, the attention was shifted to
the PCA values of the five Principal Components (PCs) in separate
experimental groups. When considering the PC1, it was clear to
find a general inclination that groups administrated by Baicalin (A,
AB, and ABC) showed higher values than others, while groups
administrated by Desoxycholic acid showed lowest values (Fig. 5).
In our anticipation, Baicalin, play the leading role in the formula,
represents a most powerful therapeutic potency in the treatments,
while Desoxycholic acid, playing a compatible role, as supposed
nearly has no therapeutic effect. This anticipation is strongly
supported by a mass of evidences [34–36]. For the dominant genes
and involved cell processes, PC2 and PC5 had similarities in
quantities and distributions. The rest PC3 and PC4 had obvious
commonness. That is, they both showed highest PCA values in
ABC, the best curative protocol, and they had the similar
quantities of dominant genes and share most of involved cell
processes. However, the PCA values of the PCs in experimental
groups were ambiguous to comprehend until they were added
together. The accumulation of values of the two provided a clear
inclination. That is, when Baicalin existed, combinations were
better than single administrations, and the performances in
combined groups were influenced by the grades of the separate
herbal components and their dosages. Therefore, we also
considered the additive form of their values and found that except
the polarized ABC and AB, rest experimental groups nearly had a
same performance (Fig. 6). This manifestation just accorded with
the principle of herbal formulae (Fang-Ji), emperor-minister-
adjuvant-courier (Jun-Chen-Zuo-Shi) [37]. In a traditional
formula, emperor aims at the cardinal pathological symptom of
a disease, playing a key role in the treatments. Minister may assist
emperor or treat other secondary symptoms, if applicable.
Adjuvant/courier mainly co-ordinates the formula, facilitating
performances of emperor and minister and decreasing their side
effects. According these, in refined QKL, Baicalin is the emperor;
Jasminoidin might be as the minister, and Desoxycholic acid used
in the compounds as the adjuvant/courier.
In the term of genes’ direct expressions, from dominant genes of
PC1, we screened seven genes which manifested the highest ratios
in group A among all the experimental groups, to analyze the
specific potency of Baicalin, the emperor of the formula.
Interestingly, the seven genes, BDNF, CRKL, FZD7, RARA,
RARB, RGS5 and TGF-b1, are all specific in PC1 but have a
wide-range distribution in cell. BDNF and TGF-b1, the growth
factors located in extracellular matrix, both play a comprehensive
role in neuroprotection after ischemia through ERK pathway or
SMAD family, respectively as the important extracellular signals
[38,39]. RARA, RARB and FZD7, the receptors located in
plasma member, participated in receiving signaling of anti-oxidant
injury and vascular development [40,41]. Located in cytoplasm,
CRKL and RGS5 play a role in nerve system development
[42,43]. Noticeably, BDNF and TGF-b1, the two essential factors
in the neuroprotective function, showed a decreasing inclination as
the doses of Baicalin decreased in experimental groups, which
implied the Baicalin’s potency as emperor in the formula. In the
dominant genes of PC 3 and PC 4, we screened eleven genes
showed the highest ratios in the group ABC among all the
experimental groups, to study the integrated effect of ABC.
Among these genes, ten shared with other types of PCs, while only
ELK3, a transcription factor which has been reported to be
Figure 5. The association between values of each PCs with drugs combination. 5a showed that drug A (Baicalin) matched PC 1, which
offered a potency of the principal therapeutic effect. 5b suggested that drug B (Jasminoidin) matched PC 2 + PC 5, which showed the supplementary
role on pharmacodynamics. 5c showed that drug C (Desoxycholic acid) only played some compatible effect on the contribution of
pharmacodynamics.
doi:10.1371/journal.pone.0045811.g005
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important in vascular development [44], was specific in PC3 and
PC4. Furthermore, SHC1 forms an important receptor protein,
participating in some anti-ischemic processes, such as proliferation
and cell survival. However, it was also reported to catalyze
formation of ROS, related to reperfusion damage [45]. SMAD3,
BARHL1 and CREM are all transcription factors, playing roles in
cell differentiation and proliferation. Especially, SMAD3 and
members of its family, transducting the signaling of TGF-b, are the
important protective factor in ischemia/reperfusion [38]. ADCY3
is an adenylate cyclase, catalyzing the formation of cAMP. NKD 1
is a dishevelled-binding protein that functions as a negative
regulator of the Wnt-beta-catenin-Tcf signaling pathway [46].
HSPA1A is involved in cell attachment as a molecular chaperon,
playing a role in ATP-depletion cytoprotection [47]. MGAT1
plays a major role in energy absorption, due to its function in
catalyzing the synthesis of diacylglycerol, the precursor of
physiologically important lipids such as triacylglycerol and
phospholipids [48]. FREQ regulates exocytosis through mediating
increased pohosphinositide turnover and Ca2+ signaling [49] and
HTR2C is a part of serotonin receptor, both of which participate
in neurotransmission. Summarily, the selected genes are evidently
implicated in varied ischemia or nerve system related pathways,
which suggested that the great integrated effect of ABC might be
derived from the equilibrium of the multiple physiological
processes, rather than a powerful therapeutic efficacy in one main
process. In the PC2 and PC5, there were twenty one dominant
genes showing highest ratios in group AB, so we selected them as
delegates of the function of the Minister of the formula. Among
extracellular factors, interleukin 1 alpha (IL1a) and colony
stimulating factor 1 (CSF1) are important cytokines related to
ischemic injury. IL1a was reported to enhance neuronal damage
through inflammation [50], while it was also regarded to play a
role in neuroprotection to excitotoxin mediated by NMDA [51].
CSF1 has been determined to be effective in neuronal survival in
cerebral ischemic lesion [52]. The other two, WIF1 and DKK2,
were members of Wnt pathway, which plays a role in resisting
development of neuronal death [53]. There were seven proteins
located in nucleus, ex. DAXX, TCF12, CASP2, TBP, HDAC1,
IKBKG and Taf7. All of them participate in transcription, except
CASP2, which may be involved in apoptosis, as well as BAD and
CASP7 in cytoplasm. The other proteins in cytoplasm or
membrane, such as TRAF2, GAK, MKNK1, Rgs6, GAB1,
HTR3A and HTR1A, were mainly implicated in cellular signaling
transduction. Importantly, the essential neuroprotective protein,
nerve growth factor [54], also showed a dramatic increase in the
AB. Summarily, the dominant genes in PC 2 and PC 5 provided
extra main neuroprotective pathways other than PC 1, which
suggested a compensatory role of jasminoidin as the Minister in
this formula.
Conclusion
We firstly presented the synergism and combinational rules of
refined Qing-Kai-Ling to treat ischemic stroke mice model
through conventional neurobiological methods combined with
PCA of microarray. TCM is a comprehensive and abstruse
subject, which has accumulated a mass of clinical experience but
absence of a systematical theory and scientific explanation. Our
approach successfully simulated the therapeutic ways by extracting
Figure 6. Distribution of experimental groups in the theoretic model of TCM combined therapy. The three axes in the 3D space reflect
three emphases of TCM combined therapy, principal therapeutic potency, assistant or compensatory helper and compatibility of a formula. In the
present study, group A displayed a greatest principal therapeutic potency, but group ABC achieved a maximized equilibrium for the three aspects.
doi:10.1371/journal.pone.0045811.g006
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principal components, according to the classic herbal drug-
combination theory, emperor-minister-adjuvant-courier, which is
a fundamental philosophy of TCM. This study might be
considered to provide a new sight to investigate and understand
the molecular mechanism of TCM, because it was a pilot attempt
to explain combination theory of TCM in aspect of holism. On the
other hand, we also indicated the PCA of information technology




Male KunMing mice weighing (4565 g) were purchased from
the laboratory animal center of Peking University (certificate
No. 2005-0004). They were housed under standard laboratory
conditions. Food and water were provided ad libitum. The middle
cerebral artery occlusion reperfusion model (MCAO) was
prepared according to the method described previously [25,26].
In short, animals were anesthetized with 2% sodium pentobarbi-
turate solution (4 mg/kg weight, i.p.). A midline neck incision was
made. The left common carotid artery, the left external carotid
artery (ECA) and the left inner carotid artery were exposed. After
a ligation in the distal part, an incision was made in the left
external carotid near the carotid bifurcation. A 4 to 0 monofil-
ament nylon suture coated with silicon was inserted through this
incision and gently advanced into the internal carotid artery. The
filament was sent into the intracranial portion of the internal
carotid and positioned 1160.5 mm from the carotid bifurcation.
By this method, a large infarct in the territory of the middle
cerebral artery is typically produced. Body temperature measured
in the temporal muscle was maintained at 3760.5uC with a heated
water-blanket under feedback control during the period of
ischemia. Reperfusion was performed by withdrawal of the
inserted filament after 1.5 hours. Animals in the sham-operation
group underwent the same procedures as described above with the
exception of the insertion of the nylon filament into the inner
carotid. 10 mice were randomly selected and assigned to the sham-
operation group (N). 176 mice survived from the MCAO
operation were randomly assigned to rest 8 groups: (1) the MCAO
model group (M), (2) the baicalin-treated group (A), (3) the
jasminoidin-treated group (B), (4) the desoxycholic acid-treated
group (C), (5) the combination of baicalin and jasminoidin-treated
group (AB), (6) the combination of baicalin and desoxycholic acid-
treated group (AC), (7) the combination of jasminoidin and
desoxycholic acid-treated group (BC) and (8) the combination of
baicalin, jasminoidin and desoxycholic acid-treated group (ABC).
All the animal experiments were performed according to the
Prevention of Cruelty to Animals Act 1986 and NIH Guidelines
for Care and Use of Laboratory Animals and local laws. People
who analyzed the subsequent data did not know this assignment.
Drug administration
Baicalin, jasminoidin and desoxycholic acid were kindly
supplied by the pharmaceutical factory affiliated with Beijing
University of Chinese Medicine. The individual ingredients in
refined QKL are baicalin 6.25 g/L, jasminoidin 12.5 g/L, and
desoxycholic acid 7 g/L [9]. According to the results of initial
experiments on the dosage selecting of QKL (data not show), we
determined individual into animal administration dosage, i.e.
baicalin (20 mg/kg) for A group, jasminoidin (100 mg/kg) for B
group, and desoxycholic acid (28 mg/kg) for C group. In order to
highlight the synergism of combinational drugs, the half of dosage
was tested for combination of pairs, and one third of dosage was
tested for combination of all, i.e. baicalin (10 mg/kg) and
jasminoidin (50 mg/kg) mixture for AB group, baicalin (10 mg/
kg) and desoxycholic acid (14 mg/kg) mixture for AC group,
jasminoidin (50 mg/kg) and desoxycholic acid (14 mg/kg) mixture
for BC, baicalin (6.67 mg/kg), jasminoidin (33.3 mg/kg) and
desoxycholic acid (9.3 mg/kg) mixture for ABC group. The drugs
were administrated in saline and injected from the tail vein (i.v.)
with 4 ml/kg solution just before reperfusion. Animals in the sham
operation group and the MCAO model group received an
injection of 4 ml/kg saline with the same method as mentioned
above.
Neurological examination
24 hours after reperfusion, sixteen mice of each group were
subjected to a neurological examination according to the method
established by Bederson, et al [27]. The postural reflex test and the
forelimb placing test were performed. The neurologic deficit
degree was graded by 0 to 3 score (normal = 0; the worst = 3).
TTC staining
24 hours after reperfusion, in each group, the sixteen mice for
neurological examination were anesthetized with chloral hydrate
(400 mg/kg) and decapitated. The brains were removed and
sectioned into five 2 mm-thick coronal slices. The slices were
stained with 1% of 2,3,5-triphenyltertrazolium chloride (TTC,
Sigma) in 0.1 M PBS (pH 7.4) for 30 minutes, room temperature
(RT), and fixed with 10% buffered formalin overnight. They were
photographed with a digital camera (Color CCD camera TP-
6001A, Topica). The infarct volumes were measured by Pathology
Image Analysis System (Topica Inc, Japan). And in each sample,
the total infarction volume and the total slice volume were
collected from the five slices, and then the infarction volume ratio
was calculated as dividing the total infarction area by the total slice
area.
Microarray Experiments and data analysis
A cDNA microarray was manufactured by mechanical spotting
on glass slides with Array Spotter Generation III (Molecular
Dynamics Inc.). This microarray contained 373 cDNA derived
from a cDNA library (Invitrogen, Cat.1065-025). Each clone was
sequence-verified, whereas each cDNA represented one gene.
These genes were selected as ischemia-related genes concluded
from our previous work [55] and other published papers, which
included the genes related to the signal transduction pathway [56–
60] and cascade reaction corresponding to cerebral ischemia
combined with neural protection and injured factors [61–63].
Three animals in each group were randomly selected to extract
RNA. Three hours after reperfusion, animals were decapitated,
and the brains were removed under RNAse-free conditions. The
left cerebral hemisphere was carefully dissected out. Tissues were
placed into Trizol reagent (Life Technologies, Gibco, Rockville,
MD), and then homogenized. Total RNA was extracted with
chloroform and isopropyl alcohol and purified with a RNAeasy kit
(Qiagen, Valencia, CA). The quality of RNA was ensured with an
eletrophoresis in 1% agarose gel.
RNA of the three samples in the MCAO group was pooled as
one. For each microarray analysis, 50 mg total RNA of each
sample was used. cDNA was reverse-transcripted from RNA and
labelled with Cy5(MCAO group) or Cy3(drug treated or sham
operation groups), with ampliscribe T7(Epicenter, Madison, WI,
USA). cDNA was then hybridized to the microarray at 42uC in a
buffer containing 50% formamide, 56SSC, 0.1%SDS, 0.25 mg/ml
human cotl DNA and 0.125 mg/ml poly-dA, for 16 hours. The
hybridized chip was washed with a series of SSC/SDS solutions.
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After washing, slides were immediately scanned on an Axon Gene
Pix 4000B and quantified using Axon GenePix Pro (Axon, Union
city, CA, USA). Data were analyzed using GeneSpring (Silicon
Genetics, Redwood City, CA, USA). The data were normalized
through housekeeping gene correction and LOWESS method. At
last, there were three independent microarray results in each drug-
treated group. We compared gene expressions in drug-treated
groups with that in the MCAO group, as well as compared gene
expressions among drug-treated groups.
Real-time RT-PCR Analysis
Real-Time PCR (50 ml) was performed with Thermo-fast 96
PCR plates(Bio-Rad Laboratories, Hercules, Calif.), which were
sealed with iCycler IQ optical-quality tapes (Bio-Rad Laborato-
ries) on an iCycler IQ thermocycler (Bio-Rad Laboratories). Each
measurement was performed in three replicates. A dilution series
of positive control DNA was used inthe same plates as the
calibration standards. Positive control DNA was generated by the
amplification of the gene from samples. The amplicon was
purified, cloned into TOPO TA cloning vector (Invitrogen), and
reamplified. After purification, the concentrations of PCR
products were determined using a fluorometer as described above
and were serially diluted to generate calibration standards. Data
analysis was carried out with iCycler software (Bio-Rad Labora-
tories). Based on the standard curve, a threshold cycle measured in
a sample was converted to the copy number of the gene in a
sample.
Statistical and gene expression profile Analysis
Data were represented as mean6SD. Data were analyzed with
SPSS 17.0 software. In all the cases, One-Way ANOVA and t test
were used for comparisons between multiple groups and two
groups, respectively. P,0.05 was considered as statistically
significant.
Gene data were analyzed through the use of Ingenuity pathway
Analysis (IPA), Ingenuity systems, www. ingenuity. com. In brief, a
data set containing gene identifiers and corresponding expression
fold change values was uploaded into the application. Each gene
identifier was mapped to its corresponding gene object in the
ingenuity pathway knowledge base.
The principal component analysis was run following the
algorithms. Briefly, Let X[RN|K be the gene data from xxx
subjects with N genes and K experimental conditions. In our
study, we mainly recorded 373 representations in gene chips in 7
different combinations of three drug components (A, B and C).
Before feature selection, the gene values from multiple subjects are
firstly averaged to enhance the data quality. We used S to
represent the covariance of X and PCA essentially pursuits the
following eigenvalue decomposition problem
Sw~lw: ð1Þ
Here, l is the eigenvalue of X. We selected the largest five
eigenvalues whose overall contribution is 96.89%. They represent
the five most important drug functions. w[R1|K is a calculated
eigenvector which can depict the contribution of every gene to one
functional component. After normalizing each vector, we com-
bined them and generated a projection matrix W[R5|N . Then
373 genes values were transformed to five principal response
components in 7 conditions by applying W to the gene data
D~WX : ð2Þ
In the aspect of principal gene analysis, we accumulated and
normalized one gene’s PCA scores of all the experimental groups,
to investigate the power of a gene in a PC. Then we set a threshold
of 60.2 to screen the dominant genes in a PC, because in any PC,
most of genes were normally distributed between 20.2–0.2 with a
minority of influence but genes distributed outside of 20.2–0.2
had a majority of influence to the PC. To annotate function of
genes, we applied Pathway studio 5.0 (updated pathway in Dec
7th, 2010) to analysis the outcome of each PC.
Supporting Information
Figure S1 Validation of microarray results (tiff). The
real-time PCR results figured out the similar profiles with the
outcome of microarray. The results suggested that array based
gene expression measurements were reliable. Noted: blue columns
show the results of real time PCR; red columns show microarray
results.
(TIF)
Table S1 Selected 46 drug-target genes (excel). The
yellow highlight show the common genes affected by each
combination of drugs.
(DOC)
Table S2 The dominant genes in the five principal
components (PCs) (excel). A gene whose absolute normalized
score in a PC more than 0.2 was selected as a dominant gene. A
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